12,750-share stock-option sale listed for CVNA (NYSE: CVNA) on 04/01/2026
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
CVNA Form 144 reports a proposed sale of 12,750 common shares on 04/01/2026 tied to an exercise of stock options and a cash transaction through Morgan Stanley Smith Barney LLC. The filing also lists three prior 10b5-1 sales by Mark Jenkins of 12,750 shares each on 01/02/2026, 02/02/2026 and 03/02/2026 with the gross proceeds shown in the excerpt.
Positive
- None.
Negative
- None.
Key Figures
Proposed shares to be sold: 12,750 shares
Prior 10b5-1 sale - Mar: 12,750 shares
Prior 10b5-1 sale - Feb: 12,750 shares
+2 more
5 metrics
Proposed shares to be sold
12,750 shares
04/01/2026, exercise of stock options
Prior 10b5-1 sale - Mar
12,750 shares
03/02/2026, proceeds $4,120,162.00
Prior 10b5-1 sale - Feb
12,750 shares
02/02/2026, proceeds $5,229,874.60
Prior 10b5-1 sale - Jan
12,750 shares
01/02/2026, proceeds $5,138,510.80
Proceeds shown for proposed sale line
$4,008,345.00
04/01/2026 line in excerpt
Key Terms
Form 144, 10b5-1 Sales, Exercise of Stock Options, Morgan Stanley Smith Barney LLC
4 terms
Form 144 regulatory
"144: Filer Information 144: Issuer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 Sales regulatory
"10b5-1 Sales for MARK JENKINS 300 E. Rio Salado Parkway"
Exercise of Stock Options financial
"Common | 04/01/2026 | Exercise of Stock Options | Issuer"
Morgan Stanley Smith Barney LLC other
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"
FAQ
What does CVNA's Form 144 report?
Answer: The Form 144 reports a proposed sale of 12,750 CVNA common shares on 04/01/2026 tied to an exercise of stock options and processed in cash through Morgan Stanley Smith Barney LLC, as shown in the excerpt.
Who is listed as the broker or intermediary for the sale in CVNA's filing?
Answer: The excerpt lists Morgan Stanley Smith Barney LLC at 1 New York Plaza, 8th Floor, New York, NY, as the securities intermediary handling the proposed sale on 04/01/2026 in the filing.
Does the filing show prior insider sales for CVNA?
Answer: Yes. The filing lists three prior 10b5-1 sales by Mark Jenkins of 12,750 shares each on 01/02/2026, 02/02/2026, and 03/02/2026, with gross proceeds reported for each transaction.
What proceeds are shown for the transactions in the CVNA excerpt?
Answer: The excerpt shows numeric proceeds: $4,008,345.00 (associated with the 04/01/2026 line) and prior 10b5-1 sale proceeds of $5,129,510.80, $5,229,874.60, and $4,120,162.00 next to their respective dates.